Clinical trial
Efficacy of Higher vs. Lower Doses of Dexamethasone in Patients With Acute Hypoxemic Respiratory Failure (Including ARDS) Caused by Infections (Including COVID-19)
NCT04545242 is registered in ClinicalTrials.gov with Hospital Universitario de Gran Canaria Doctor Negrín as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Higher vs. Lower Doses of Dexamethasone in Patients With Acute Hypoxemic Respiratory Failure (Including ARDS) Caused by Infections (Including COVID-19)
- Lead sponsor
- Hospital Universitario de Gran Canaria Doctor Negrín
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 6, 2020
- Completion date
- December 30, 2020
- Enrollment
- 980 (actual)
- Sites
- 40
Conditions
As the registry lists them; a condition with its own page is linked.
acute hypoxemic respiratory failure